Inhaled steroid ciclesonide suppresses SARS-CoV-2 replication in vitro
A new paper by researchers at Japan’s National Institute of Infectious Diseases and published on the preprint server bioRxiv in August 2020 reports the in vitro suppression of coronavirus (CoV) replication by an inhaled corticosteroid (ICS) ciclesonide.
.png)
No hay comentarios:
Publicar un comentario